Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced the launch of Tris-labeled generic TUSSIONEX®, an extended-release suspension containing ...
LONDON, Feb 10 (Reuters) - UK pharmaceutical group Vernalis has struck a deal with U.S. firm Tris Pharma to develop slow-release products for the U.S. prescription cough and cold market - and raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results